Zealand Pharma A/S
ZLDPF
$40.99
-$0.01-0.02%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.40B | 1.39B | 1.39B | 8.01M | 9.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.40B | 1.39B | 1.39B | 8.01M | 9.07M |
| Cost of Revenue | 119.50K | 177.80K | -797.70K | 509.10K | 1.12M |
| Gross Profit | 1.40B | 1.39B | 1.39B | 7.50M | 7.95M |
| SG&A Expenses | 75.51M | 83.21M | 67.14M | 62.00M | 58.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 29.64M | 29.64M | 29.64M | 3.04M | -- |
| Total Operating Expenses | 349.58M | 311.01M | 282.66M | 212.14M | 193.03M |
| Operating Income | 1.05B | 1.08B | 1.10B | -204.13M | -183.96M |
| Income Before Tax | 1.07B | 1.09B | 1.11B | -171.06M | -157.05M |
| Income Tax Expenses | 83.14M | 87.33M | 81.26M | -668.60K | -671.40K |
| Earnings from Continuing Operations | 982.34 | 999.84 | 1.02K | -170.39 | -156.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 982.34M | 999.84M | 1.02B | -170.39M | -156.38M |
| EBIT | 1.05B | 1.08B | 1.10B | -204.13M | -183.96M |
| EBITDA | 1.06B | 1.08B | 1.11B | -201.02M | -180.73M |
| EPS Basic | 13.88 | 14.13 | 14.47 | -2.49 | -2.36 |
| Normalized Basic EPS | 9.29 | 9.54 | 9.69 | -1.64 | -1.55 |
| EPS Diluted | 13.65 | 13.91 | 14.25 | -2.49 | -2.36 |
| Normalized Diluted EPS | 9.14 | 9.39 | 9.55 | -1.64 | -1.55 |
| Average Basic Shares Outstanding | 281.98M | 282.37M | 282.73M | 274.69M | 265.72M |
| Average Diluted Shares Outstanding | 282.97M | 283.35M | 283.71M | 274.69M | 265.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |